DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Tolosa E, Litvan I, Höglinger GU. , et al; TAUROS Investigators.
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy.
Mov Disord 2014;
29 (04) 470-478
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.